Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075]

Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075]

Saved in:

Bibliographic Details
Main Authors:	Kiyotaka Uchiyama, Daisuke Kamano, Tomoki Nagasaka, Eriko Yoshida Hama, Ryoichi Shirai, Rena Sumura, Ei Kusahana, Akane Yanai, Takashin Nakayama, Takahide Kimura, Rina Takahashi, Takahiro Kasai, Takaya Tajima, Koji Hosoya, Tatsuhiko Azegami, Shintaro Yamaguchi, Jun Yoshino, Jun Ito, Matsuhiko Hayashi, Takeshi Kanda, Yoshitaka Ishibashi, Naoki Washida, Hiroshi Itoh, Kaori Hayashi
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024925003274
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan
by: Kiyotaka Uchiyama, et al.
Published: (2025-04-01)

Kidney Function Trajectories with Tolvaptan in ADPKD Patients with CKD-G5
by: Akinari Sekine, et al.
Published: (2025-06-01)

Cost-Minimization Analysis of Tolvaptan Treatment for ADPKD in Southern Spain
by: Francisco J. Roca Oporto, et al.
Published: (2025-01-01)

Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes
by: Liliana Italia De Rosa, et al.
Published: (2025-08-01)

Response to the Letter to the Editor Entitled “Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes”
by: Neera K. Dahl, et al.
Published: (2025-08-01)

Intraabdominal fat-free volume, but not fat volume, predicts the development of peritonitis in patients on peritoneal dialysis: a retrospective cohort study
by: Ryunosuke Mitsuno, et al.
Published: (2025-06-01)

Early Initiation of Tolvaptan is Associated with Early Discharge in Elderly Heart Failure Patients
by: Shunsuke Kiuchi, et al.
Published: (2021-12-01)

IFT140-related ADPKD
by: Martina Catania, et al.
Published: (2025-02-01)

PubChem BioAssays 1063: A Poorly Exploited Source of New Antileishmanial Compounds
by: Sergio Sifontes-Rodríguez, et al.
Published: (2025-01-01)

Biomarkers of Kidney Disease Progression in ADPKD
by: Ahmad Ghanem, et al.
Published: (2024-10-01)

The proteinuria selectivity index value predicts the remission of IgA nephropathy: a retrospective cohort study
by: Ryunosuke Mitsuno, et al.
Published: (2024-12-01)

WCN24-1075 A MACHINE LEARNING-PREDICTIVE MODEL TO IDENTIFY FACTORS ASSOCIATED WITH DEATH IN DIALYSIS PATIENTS
by: Daniela Ponce, et al.
Published: (2024-04-01)

Acute Kidney Injury in ADPKD Patients with Pneumonia
by: Carlos Franco Palacios, et al.
Published: (2011-01-01)

Risk Factors Affecting the Severity, Mortality, and Intensive Care Unit Admission of COVID-19 Patients: A Series of 1075 Cases
by: Ecem Narin Çopur, et al.
Published: (2025-03-01)

Perspectives of Patients and Clinicians on Reproductive Health Care and ADPKD
by: Margriet E. Gosselink, et al.
Published: (2024-11-01)

Patients With Mild ADPKD by Kidney Imaging but Low Estimated GFR
by: Seung Heyck Lee, et al.
Published: (2025-06-01)

How Does ADPKD Severity Differ Between Family Members?
by: Klement C. Yeung, et al.
Published: (2024-05-01)

Developing serum proteomics based prediction models of disease progression in ADPKD
by: Hande Ö. Aydogan Balaban, et al.
Published: (2025-07-01)

Exploring the role of ketogenic diet in ADPKD treatment: A promising avenue
by: Abdul Mutaal, et al.
Published: (2024-10-01)

Syndrome of Inappropriate Antidiuretic Hormone Secretion and Ibuprofen, a Rare Association to Be Considered: Role of Tolvaptan
by: Nathan Artom, et al.
Published: (2013-01-01)

Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand
by: Permsuwan U, et al.
Published: (2025-07-01)

An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD
by: Jonathan Taylor, et al.
Published: (2024-02-01)

Sporadic ADPKD-IFT140: Absence of Family History as an Indicator of Clinical Mildness
by: Manuel A. Anderegg, et al.
Published: (2024-09-01)

Post-hepatectomy tolvaptan-induced hypernatremia in a hepatocellular carcinoma patient with cirrhosis: a case report
by: Hiroya Iida, et al.
Published: (2020-03-01)

Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for Tolvaptan and Mambaquaretin toxin
by: Aurélien Fouillen, et al.
Published: (2025-04-01)

Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis.
by: Mei-Yi Wu, et al.
Published: (2017-01-01)

WCN25-4041 A rare case of large sub serosal fibroid associated with ADPKD
by: Gita Bipin Chandra, et al.
Published: (2025-02-01)

Early Detection Matters: Bridging Evidence and Practice, a Call for Enhanced Cardiovascular Screening in ADPKD
by: Martina Catania, et al.
Published: (2025-02-01)

Segmentation of ADPKD Computed Tomography Images with Deep Learning Approach for Predicting Total Kidney Volume
by: Ting-Wen Sheng, et al.
Published: (2025-01-01)

Correction: Olugbodi et al. Silver Nanoparticles Stimulates Spermatogenesis Impairments and Hematological Alterations in Testis and Epididymis of Male Rats. <i>Molecules</i> 2020, <i>25</i>, 1063
by: Janet Olayemi Olugbodi, et al.
Published: (2025-02-01)

Understanding Familial Variability in ADPKD: A Comprehensive Approach Integrating Genetics, Hormones, and Lifestyle for Tailored Management
by: Martina Catania, et al.
Published: (2025-01-01)

Response to Early Detection Matters: Bridging Evidence and Practice, a Call for Enhanced Cardiovascular Screening in ADPKD
by: Priyanka S. Sagar, et al.
Published: (2025-02-01)

The impact of tolvaptan on the incidence of contrast-induced acute kidney injury and long-term prognosis in high-risk patients after coronary intervention
by: Chunyang Xu, et al.
Published: (2025-12-01)

Response to ”Understanding Familial Variability in ADPKD: a Comprehensive Approach Integrating Genetics, Hormones, and Lifestyle for Tailored Management”
by: Elhussein A.E. Elhassan, et al.
Published: (2025-01-01)

WCN25-4599 ROLE OF METFORMIN IN ADPKD: EXPERIENCE FROM A TERTIARY CARE CENTRE IN EASTERN INDIA
by: Aniruddha Datta, et al.
Published: (2025-02-01)

Corrigendum to “BRTO for ectopic small intestinal varices bleeding via dilated superior mesenteric veins and left ovarian vein: A case report”. [Radiol Case Rep 2 0 (2025) 1058–1063]
by: Weicheng Wang, MS, et al.
Published: (2025-07-01)

WCN24-1689 DISEASE PROGRESSION AND WATER BALANCE IN ADPKD: THE ROLE OF TOTAL AND EXTRACELLULAR VESICLE cAMP CONTENTS IN URINE
by: MARIA LUCIA ROSENBERG, et al.
Published: (2024-04-01)

Effectiveness of tolvaptan on renal replacement therapy in patients with autosomal dominant polycystic kidney disease: a retrospective cohort study from the TriNetX global collaborative network
by: Ming-Ju Wu, et al.
Published: (2024-12-01)

Safety of Polyethylene Glycol Solution plus Ascorbic Acid for Bowel Preparation for Colonoscopy in Patients with Chronic Kidney Disease
by: Naoki Ohmiya, et al.
Published: (2021-01-01)

A phase I study to evaluate the effect of high-dose carbidopa on levodopa pharmacokinetics
by: Akane Hayashi, et al.
Published: (2025-07-01)